Literature DB >> 20569644

Oxidative damage to RNA but not DNA in the hippocampus of patients with major mental illness.

Yi Che1, Jun-Feng Wang, Li Shao, Trevor Young.   

Abstract

BACKGROUND: Oxidative damage in the central nervous system is increasingly recognized as an important pathological process in many diseases. Previously, our laboratory found that oxidative damage to lipids and proteins was increased in postmortem brain tissue from patients with bipolar disorder and schizophrenia. In the current study, we analyzed oxidative damage to nucleic acids in the CA1, CA3 and dentate gyrus regions of postmortem hippocampus tissue from patients with bipolar disorder, schizophrenia and major depression.
METHODS: We examined oxidative damage to nucleic acids by performing immunohistochemistry with a monoclonal antibody that recognizes both 8-hydroxy-guanosine in RNA and 8-hydroxy-2'-deoxyguanosine in DNA.
RESULTS: We found that the amount of oxidative damage to nucleic acids was elevated in the CA1, CA3 and dentate gyrus regions of the hippocampus among patients with bipolar disorder, schizophrenia and major depressive disorder. This damage was predominantly in the cytoplasm, suggesting that the damage was primarily to RNA. Compared with oxidative damage in control samples, the magnitude of damage was high in patients with schizophrenia, modest in patients with bipolar disorder and lower in patients with major depression. LIMITATIONS: The interpretation of our results is limited by a number of factors, including the retrospective review of patient history, the relatively small sample size and the inclusion of patients who had substance abuse and were undergoing various drug treatments at the time of death.
CONCLUSION: Our results suggest that oxidative damage to RNA, rather than to DNA, occurs in vulnerable neurons of the brain in patients with major mental illness and may contribute to the pathology of these disorders. The magnitude of RNA oxidative damage may be associated with the severity of mental illness.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20569644      PMCID: PMC2928282          DOI: 10.1503/jpn.090083

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN: 1180-4882            Impact factor:   6.186


  42 in total

Review 1.  The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications.

Authors:  Paul J Harrison
Journal:  Psychopharmacology (Berl)       Date:  2004-03-06       Impact factor: 4.530

2.  Alterations of mitochondrial function and correlations with personality traits in selected major depressive disorder patients.

Authors:  Ann Gardner; Anna Johansson; Rolf Wibom; Inger Nennesmo; Ulrika von Döbeln; Lars Hagenfeldt; Tore Hällström
Journal:  J Affect Disord       Date:  2003-09       Impact factor: 4.839

3.  Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder.

Authors:  Murat Kuloglu; Bilal Ustundag; Murad Atmaca; Halit Canatan; A Ertan Tezcan; Nadire Cinkilinc
Journal:  Cell Biochem Funct       Date:  2002-06       Impact factor: 3.685

4.  The identification and characterization of oxidized RNAs in Alzheimer's disease.

Authors:  Xiu Shan; Hirofumi Tashiro; Chien-liang Glenn Lin
Journal:  J Neurosci       Date:  2003-06-15       Impact factor: 6.167

5.  Olanzapine protects PC12 cells from oxidative stress induced by hydrogen peroxide.

Authors:  Zelan Wei; Ou Bai; J Steven Richardson; Darrell D Mousseau; Xin-Min Li
Journal:  J Neurosci Res       Date:  2003-08-01       Impact factor: 4.164

6.  Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients.

Authors:  Prabhakar K Ranjekar; Ashwini Hinge; Mahabaleshwar V Hegde; Madhav Ghate; Anvita Kale; Sandhya Sitasawad; Ulhas V Wagh; Vijay B Debsikdar; Sahebarao P Mahadik
Journal:  Psychiatry Res       Date:  2003-12-01       Impact factor: 3.222

7.  Glutathione S-transferase is a novel target for mood stabilizing drugs in primary cultured neurons.

Authors:  Jun-Feng Wang; Li Shao; Xiujun Sun; L Trevor Young
Journal:  J Neurochem       Date:  2004-03       Impact factor: 5.372

8.  Molecular evidence for mitochondrial dysfunction in bipolar disorder.

Authors:  Christine Konradi; Molly Eaton; Matthew L MacDonald; John Walsh; Francine M Benes; Stephan Heckers
Journal:  Arch Gen Psychiatry       Date:  2004-03

9.  Molecular abnormalities of the hippocampus in severe psychiatric illness: postmortem findings from the Stanley Neuropathology Consortium.

Authors:  Michael B Knable; Beata M Barci; Maree J Webster; James Meador-Woodruff; E Fuller Torrey
Journal:  Mol Psychiatry       Date:  2004-06       Impact factor: 15.992

10.  Lateralized abnormality of high energy phosphate metabolism in the frontal lobes of patients with bipolar disorder detected by phase-encoded 31P-MRS.

Authors:  T Kato; T Shioiri; J Murashita; H Hamakawa; Y Takahashi; T Inubushi; S Takahashi
Journal:  Psychol Med       Date:  1995-05       Impact factor: 7.723

View more
  39 in total

Review 1.  Oxidative damage to RNA in aging and neurodegenerative disorders.

Authors:  Akihiko Nunomura; Paula I Moreira; Rudy J Castellani; Hyoung-Gon Lee; Xiongwei Zhu; Mark A Smith; George Perry
Journal:  Neurotox Res       Date:  2012-06-06       Impact factor: 3.911

2.  Oxidatively-induced DNA damage and base excision repair in euthymic patients with bipolar disorder.

Authors:  Deniz Ceylan; Gamze Tuna; Güldal Kirkali; Zeliha Tunca; Güneş Can; Hidayet Ece Arat; Melis Kant; Miral Dizdaroglu; Ayşegül Özerdem
Journal:  DNA Repair (Amst)       Date:  2018-03-30

3.  Peripheral antioxidant markers are associated with total hippocampal and CA3/dentate gyrus volume in MDD and healthy controls-preliminary findings.

Authors:  Daniel Lindqvist; Susanne Mueller; Synthia H Mellon; Yali Su; Elissa S Epel; Victor I Reus; Rebecca Rosser; Laura Mahan; R Scott Mackin; Tony T Yang; Owen M Wolkowitz
Journal:  Psychiatry Res       Date:  2014-09-16       Impact factor: 3.222

4.  Reverse Transcription Past Products of Guanine Oxidation in RNA Leads to Insertion of A and C opposite 8-Oxo-7,8-dihydroguanine and A and G opposite 5-Guanidinohydantoin and Spiroiminodihydantoin Diastereomers.

Authors:  Anton Alenko; Aaron M Fleming; Cynthia J Burrows
Journal:  Biochemistry       Date:  2017-09-11       Impact factor: 3.162

Review 5.  The Impact of Stress and Major Depressive Disorder on Hippocampal and Medial Prefrontal Cortex Morphology.

Authors:  Emily L Belleau; Michael T Treadway; Diego A Pizzagalli
Journal:  Biol Psychiatry       Date:  2018-10-10       Impact factor: 13.382

6.  Oxidation and nitration in dopaminergic areas of the prefrontal cortex from patients with bipolar disorder and schizophrenia.

Authors:  Helena Kyunghee Kim; Ana Cristina Andreazza; Pok Yik Yeung; Cameron Isaacs-Trepanier; L Trevor Young
Journal:  J Psychiatry Neurosci       Date:  2014-07       Impact factor: 6.186

7.  Characterization of RNA damage under oxidative stress in Escherichia coli.

Authors:  Min Liu; Xin Gong; Ravi Kumar Alluri; Jinhua Wu; Tene' Sablo; Zhongwei Li
Journal:  Biol Chem       Date:  2012-03       Impact factor: 3.915

8.  Lithium reduces the effects of rotenone-induced complex I dysfunction on DNA methylation and hydroxymethylation in rat cortical primary neurons.

Authors:  Gustavo Scola; Helena K Kim; L Trevor Young; Mirian Salvador; Ana C Andreazza
Journal:  Psychopharmacology (Berl)       Date:  2014-04-29       Impact factor: 4.530

9.  Lipopolysaccharide-Induced Behavioral Alterations Are Alleviated by Sodium Phenylbutyrate via Attenuation of Oxidative Stress and Neuroinflammatory Cascade.

Authors:  Ashok Jangra; Chandra Shaker Sriram; Mangala Lahkar
Journal:  Inflammation       Date:  2016-08       Impact factor: 4.092

Review 10.  DNA Damage in Major Psychiatric Diseases.

Authors:  Muhammad Ummear Raza; Turan Tufan; Yan Wang; Christopher Hill; Meng-Yang Zhu
Journal:  Neurotox Res       Date:  2016-04-28       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.